QSAR analysis of N-myristoyltransferase inhibitors: Antifungal activity of benzofurans

Medicinal Chemistry Research

Volumn 18, Issue 3, 2009, Pages 206-220

  Deokar, Hemantkumar S ^a   Puranik, Purushottamachar ^b   Kulkarni, Vithal M ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

3D QSAR; Antifungal; Benzofuran analogues; GFA; N myristoyltransferase

Indexed keywords

ANTIFUNGAL AGENT; BENZOFURAN DERIVATIVE; PROTEIN N MYRISTOYLTRANSFERASE; PROTEIN N MYRISTOYLTRANSFERASE INHIBITOR;

ANTIFUNGAL ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG STRUCTURE; ENZYME INHIBITION; HYDROGEN BOND; PHYSICAL CHEMISTRY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATISTICAL ANALYSIS; STATISTICAL PARAMETERS;

EID: 68849122051     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-008-9120-5     Document Type: Article

References (30)

1. MS Benedetti M Bani 1999 Metabolism-based drug interactions involving oral azole antifungals in humans Drug Metab Rev 31 665 717 10.1081/DMR-100101941 (Pubitemid 29390406)
2. Chandavarkar MA, Kulkarni VM, Shivkumar P, Shetty RS, Bapat UR (2003) 1,2,4-Triazol-1-yl-propan-2-ol derivatives as anti-fungal agents. World Patent WO 068142.
3. MA Chandavarkar VM Kulkarni P Shivkumar RS Shetty UR Bapat 2005 Novel antifungal agents U.S. Pat Appl 0020653 A1
4. RD Cramer III JD Bunce DE Petterson IE Frank 1988 Crossvalidation, bootstrapping, and partial least squares compared with multiple regression in conventional QSAR studies Quant Struct Act Relat 7 18 25 10.1002/qsar. 19880070105
5. Devadas B, Freeman SK, Zupec ME, Lu HF, Nagarajan SR, Kishore NS et al (1997) Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity. J Med Chem 40:2609-2625. doi: 10.1021/jm970094w (Pubitemid 27347026)
6. RJ Duronio DA Towler RO Heuckeroth JI Gordon 1989 Disruption of the yeast N-myristoyl transferase gene causes recessive lethality Science 243 796 800 10.1126/science.2644694
7. Ebiike H, Masubuchi M, Liu P, Kawasaki K, Morikami K, Sogabe S et al (2002) Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Part 2. Bioorg Med Chem Lett 12:607-610. doi: 10.1016/S0960-894X(01)00808-3 (Pubitemid 34158904)
8. VM Gokhale VM Kulkarni 2000 Understanding the antifungal activity of terbinafine analogues using quantitative structure-activity relationship (QSAR) models Bioorg Med Chem 8 2487 2499 10.1016/S0968-0896(00)00178-4 (Pubitemid 30686235)
9. VM Gokhale VM Kulkarni 2000 Selectivity analysis of 5-(arylthio)-24- diaminoquinazolines as inhibitors of Candida albicans dihydrofolate reductase by molecular dynamics simulations J Comput Aided Mol Des 14 1573 4951 10.1023/A:1008189724803 (Pubitemid 30386824)
10. A Golbraikh M Shen Z Xiao Y Xiao K Lee A Tropsha 2003 Rational selection of training and test sets for the development of validated QSAR models J Comput Aided Mol Des 17 241 253 10.1023/A:1025386326946 (Pubitemid 37062785)
11. DR Johnson RS Bhatnagar LJ Knoll JI Gordon 1994 Genetic and biochemical studies of protein N-myristoylation Annu Rev Biochem 63 869 914 10.1146/annurev.bi.63.070194.004253
12. RG Karki VM Kulkarni 2001 Three-dimensional quantitative structure-activity relationship (3D-QSAR) of 3-aryloxazolidin-2-one antibacterials Bioorg Med Chem 9 3153 3160 10.1016/S0968-0896(01)00186-9 (Pubitemid 33065615)
13. RG Karki VM Kulkarni 2001 A feature based Pharmacophore for Candida albicans MyristoylCoA: protein N-myristoyltransferase inhibitors Eur J Med Chem 36 147 163 10.1016/S0223-5234(00)01202-2 (Pubitemid 32304517)
14. RG Karki VM Kulkarni 2001 Computer-aided design and synthesis of Candida albicans N-myristoyltransferase inhibitors as antifungal agents Indian Drugs 38 406 413
15. Y Kawakami A Inoue T Kawai M Wakita H Sugimoto AJ Hopfinger 1996 The rationale for E2020 as a potent acetylcholinesterase inhibitor Bioorg Med Chem Lett 4 1429 1446 10.1016/0968-0896(96)00137-X (Pubitemid 26319994)
16. PS Kharkar B Desai H Gaveria B Varu R Loriya Y Naliapara 2002 Three-dimensional quantitative structure-activity relationship of 14-dihydropyridines as antitubercular agents J Med Chem 45 4858 4867 10.1021/jm020217z (Pubitemid 35192775)
17. JK Lodge E Machelski DL Toffaletti JR Perfect JI Gordon 1994 Targeted gene replacement demonstrates that myristoyl-CoA: protein N-myristoyltransferase is essential for viability of Cryptococcus neoformans Proc Natl Acad Sci USA 91 12008 12012 10.1073/pnas.91.25.12008 (Pubitemid 24368593)
18. M Masubuchi K Ken-ichi H Ebiike Y Ikeda S Tsujii S Sogabe 2001 Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase Part 1 Bioorg Med Chem Lett 11 1833 1837 10.1016/S0960-894X(01)00319-5 (Pubitemid 32675299)
19. SR Nagarajan B Devadas ME Zupec SK Freeman DL Brown HF Lu 1997 Conformationally constrained [p-(omega-aminoalkyl)phenacetyl]-L-seryl-L-lysyl dipeptide amides as potent peptidomimetic inhibitors of Candida albicans and human myristoyl-CoA:protein N-myristoyl transferase J Med Chem 40 1422 1438 10.1021/jm9608671 (Pubitemid 27200759)
20. P Purushottamachar VM Kulkarni 2003 3D-QSAR of N-myristoyltransferase inhibiting antifungal agents by CoMFA and CoMSIA methods Bioorg Med Chem 5 3487 3497 10.1016/S0968-0896(03)00305-5 (Pubitemid 36870988)
21. AK Rappe CJ Casewit KS Colwell WA Goddard WM Skiff 1992 UFF a full periodic table force field for molecular mechanics and molecular dynamics simulations J Am Chem Soc 114 10024 10039 10.1021/ja00051a040
22. AK Rappe WA Goddard 1991 Charge equilibration for molecular dynamics simulations J Phys Chem 95 3358 3363 10.1021/j100161a070
23. D Rogers AJ Hopfinger 1994 Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationships J Chem Inf Comput Sci 34 854 866 10.1021/ci00020a020
24. N Sachan SS Kadam VM Kulkarni 2007 Human protein tyrosine phosphatase 1B inhibitors: QSAR by genetic function approximation J Enzyme Inhib Med Chem 22 267 276 10.1080/14756360601051274 (Pubitemid 47225718)
25. S Sogabe M Masubuchi K Sakata TA Fukami K Morikami Y Shiratori 2000 Crystal structures of Candida albicans N-myristoyltransferase with two distinct inhibitors Chem Biol 9 1119 1128 10.1016/S1074-5521(02)00240-5
26. TT Talele SS Kulkarni VM Kulkarni 1999 Development of pharmacophore alignment models as input for comparative molecular field analysis of a diverse set of azole antifungal agents J Chem Inf Comput Sci 39 958 966 10.1021/ci990020o
27. J Verma VM Khedkar AS Prabhu SA Khedkar AK Malde EC Coutinho 2008 A comprehensive analysis of the thermodynamic events involved in ligand-receptor binding using CoRIA and its variants J Comput Aided Mol Des 22 91 104 10.1007/s10822-008-9172-0
28. NK Wagh HS Deokar DC Juvale SS Kadam VM Kulkarni 2006 3D-QSAR of histone deacetylase inhibitors as anticancer agents by genetic function approximation Indian J Biochem Biophys 43 360 371
29. RA Weinberg CA McWherter SK Freeman DC Wood JI Gordon SC Lee 1995 Genetic studies reveal that myristoylCoA: protein N-myristoyltransferase is an essential enzyme in Candida albicans Mol Microbiol 16 241 250 10.1111/j.1365-2958.1995.tb02296.x
30. C Wilcox JS Hu EN Olson 1987 Acylation of proteins with myristic acid occurs cotranslationally Science 238 275 278 10.1126/science.3685978